Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial

Yue-Mei Hu; Zhao-Feng Bi; Ya Zheng; Li Zhang; Feng-Zhu Zheng; Kai Chu; Ya-Fei Li; Qi Chen; Jia-Li Quan; Xiao-Wen Hu; Xing-Cheng Huang; Kong-Xin Zhu; Ya-Hui Wang-Jiang; Han-Min Jiang; Xia Zang; Dong-Lin Liu; Chang-Lin Yang; Hong-Xing Pan; Qiu-Fen Zhang; Ying-Ying Su; Shou-Jie Huang; Guang Sun; Wei-Jin Huang; Yue Huang; Ting Wu; Jun Zhang; Ning-Shao Xia